140 related articles for article (PubMed ID: 16918970)
1. Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.
Heukamp LC; Fischer HP; Schirmacher P; Chen X; Breuhahn K; Nicolay C; Büttner R; Gütgemann I
Histopathology; 2006 Sep; 49(3):242-7. PubMed ID: 16918970
[TBL] [Abstract][Full Text] [Related]
2. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
Ruck P; Xiao JC; Kaiserling E
Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
[TBL] [Abstract][Full Text] [Related]
5. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases.
Ohmori S; Shiraki K; Sugimoto K; Sakai T; Fujikawa K; Wagayama H; Takase K; Nakano T
Hum Pathol; 2001 Dec; 32(12):1363-70. PubMed ID: 11774170
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD34-positive sinusoidal endothelial cells in patients with HBV-associated chronic liver diseases.
Ohmori S; Shiraki K; Sugimoto K; Yamanaka Y; Yamaguchi Y; Saitou Y; Fujikawa K; Murata K; Nakano T
Int J Mol Med; 2004 Aug; 14(2):179-84. PubMed ID: 15254762
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.
Pusztaszeri MP; Seelentag W; Bosman FT
J Histochem Cytochem; 2006 Apr; 54(4):385-95. PubMed ID: 16234507
[TBL] [Abstract][Full Text] [Related]
8. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
Tátrai P; Somorácz A; Batmunkh E; Schirmacher P; Kiss A; Schaff Z; Nagy P; Kovalszky I
Am J Surg Pathol; 2009 Jun; 33(6):874-85. PubMed ID: 19194276
[TBL] [Abstract][Full Text] [Related]
9. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
Nassar A; Cohen C; Siddiqui MT
Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
[TBL] [Abstract][Full Text] [Related]
10. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
11. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
de Boer WB; Segal A; Frost FA; Sterrett GF
Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
[TBL] [Abstract][Full Text] [Related]
12. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
[TBL] [Abstract][Full Text] [Related]
13. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
[TBL] [Abstract][Full Text] [Related]
16. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS
Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
[TBL] [Abstract][Full Text] [Related]
18. Podocalyxin: a marker of blasts in acute leukemia.
Kelley TW; Huntsman D; McNagny KM; Roskelley CD; Hsi ED
Am J Clin Pathol; 2005 Jul; 124(1):134-42. PubMed ID: 15923169
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.
Gouysse G; Frachon S; Hervieu V; Fiorentino M; d'Errico A; Dumortier J; Boillot O; Partensky C; Grigioni WF; Scoazec JY
J Hepatol; 2004 Aug; 41(2):259-66. PubMed ID: 15288475
[TBL] [Abstract][Full Text] [Related]
20. CD 34 expression in chronic and neoplastic liver diseases.
Di Carlo I; Fraggetta F; Lombardo R; Azzarello G; Vasquez E; Puleo S
Panminerva Med; 2002 Dec; 44(4):365-7. PubMed ID: 12434120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]